A new treatment combining KEYTRUDA (pembrolizumab) with chemotherapy has been recommended by NICE for adults with advanced or recurrent womb […]

The Food and Drug Administration (FDA) has introduced a new program called ‘FDA PreCheck’ to help strengthen U.S. drug production.

Exonate, a pharmaceutical company, has announced plans to start a phase 2b clinical trial for its lead drug, EXN407, in

Dr. George Tidmarsh, a physician, academic, and biotech entrepreneur, has been appointed as the new director of the FDA’s Center

AstraZeneca has received a positive recommendation from NICE (the National Institute for Health and Care Excellence) for a new combination

President Donald Trump has warned 17 major drug companies that they must lower their prices to match those in other

President Trump has sent letters to major drug companies, urging them to lower prices in the U.S. to match the

4TEEN4 Pharmaceuticals has started testing a new drug called procizumab in patients with cardiogenic shock, a life-threatening condition where the

After a slow recovery in 2024, biotech companies looking to go public in 2025 may face more obstacles. While only